<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100901226</journal-id><journal-id journal-id-type="pubmed-jr-id">21622</journal-id><journal-id journal-id-type="nlm-ta">Am J Physiol Endocrinol Metab</journal-id><journal-id journal-id-type="iso-abbrev">Am J Physiol Endocrinol Metab</journal-id><journal-title-group><journal-title>American journal of physiology. Endocrinology and metabolism</journal-title></journal-title-group><issn pub-type="ppub">0193-1849</issn><issn pub-type="epub">1522-1555</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40244822</article-id><article-id pub-id-type="pmc">12171989</article-id><article-id pub-id-type="doi">10.1152/ajpendo.00058.2025</article-id><article-id pub-id-type="manuscript">NIHMS2076859</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Ketone body supported respiration in murine isolated brain mitochondria is augmented by alpha-ketoglutarate and is optimized by neuronal SCOT expression</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Davis</surname><given-names>Xin C</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>McCoin</surname><given-names>Colin S</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Morris</surname><given-names>E. Matthew</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Allen</surname><given-names>Julie</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Stierwalt</surname><given-names>Harrison D</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Franczak</surname><given-names>Edziu</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Queathem</surname><given-names>Eric D</given-names></name><xref rid="A6" ref-type="aff">6</xref><xref rid="A7" ref-type="aff">7</xref><xref rid="A8" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Fulghum</surname><given-names>Kyle L</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Puchalska</surname><given-names>Patrycja</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Crawford</surname><given-names>Peter A</given-names></name><xref rid="A6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Thyfault</surname><given-names>John P</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="A5" ref-type="aff">5</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Cell Biology &#x00026; Physiology, University of Kansas Medical Center Kansas City, Kansas</aff><aff id="A2"><label>2</label>Kansas Center for Metabolism and Obesity Research</aff><aff id="A3"><label>3</label>Department of Internal Medicine, Division of Endocrinology and Metabolism, and KU Diabetes Institute.</aff><aff id="A4"><label>4</label>Research Service, Kansas City Veterans Affairs Medical Center, Kansas City, Kansas</aff><aff id="A5"><label>5</label>Center for Children&#x02019;s Healthy Lifestyles &#x00026; Nutrition, Children Mercy Hospital, Kansas City, MO</aff><aff id="A6"><label>6</label>Department of Internal Medicine, Division of Molecular Metabolism, University of Minnesota, Minneapolis, Minnesota</aff><aff id="A7"><label>7</label>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, Minnesota</aff><aff id="A8"><label>8</label>Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author Contributions</p><p id="P2">Conceived and designed research (JPT,XCD,CSM,EMM,HDS,EF,PP,PAC), performed experiments (XCD,JA,EDQ,PP), analyzed data (XCD), interpreted results of experiments (JPT,XCD,CSM,EMM,HDS,EF,PP,PAC), prepared figures (XCD), drafted manuscript (XCD), edited and revised manuscript (XCD,JPT,CSM,EMM,HDS,EF EDQ,KLF,PP,PAC), approved final version of manuscript (XCD,JPT,CSM,EMM,EF,PP,PAC).</p></fn><corresp id="CR1">Corresponding Author: John P Thyfault. Address: University of Kansas Medical Center 2106 Olathe Blvd, 2067 Hemenway, Kansas City, KS, 66160. <email>jthyfault@kumc.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>10</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>01</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>17</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>17</day><month>6</month><year>2025</year></pub-date><volume>328</volume><issue>6</issue><fpage>E822</fpage><lpage>E832</lpage><abstract id="ABS1"><p id="P3">Ketone bodies are increasingly examined as an alternative fuel source for the known decreases in glucose utilization that occur with neurodegeneration. Here, we established a protocol to maximize ketone body respiration in isolated brain mitochondria, while quantifying acetyl-CoA and energy charge via liquid chromatography-tandem mass spectrometry in control mice compared to mice with neuron-specific deletion of succinyl-CoA-3-oxoacid-CoA transferase (SCOT), required for CoA transfer from succinyl-CoA to AcAc to support its oxidation. Maximal ADP-dependent AcAc respiration occurred at 1 mM; however, the percent increase above basal was minimal (~15%). Alpha-ketoglutarate (&#x003b1;KG) substantially increased AcAc-dependent respiration in isolated brain mitochondria, putatively through the generation of succinyl-CoA. Using mice with neuron-specific deletion of SCOT, we also examined brain mitochondrial respiration of AcAc and resulting acetyl CoA and energy charge (cellular energy availability via adenosine nucleotide ratios of ATP, ADP, and AMP). As expected, isolated brain mitochondria from SCOT-KO mice had lower AcAc State 3 respiration than control mice. Surprisingly, we did not find differences in mitochondrial energy charge between SCOT control and neuron SCOT-KO mice despite decreased acetyl-CoA level in SCOT-KO mice when AcAc was used as the substrate. In conclusion, we show that &#x003b1;KG enhances ketone-supported respiration rate in isolated brain mitochondria, and ketone metabolism in neurons affects acetyl-CoA level in brain mitochondria but not energy charge. Future work will determine if diet, exercise, sex, or age impacts ketone-supported respiration rates in conjunction with differences in markers of brain health.</p></abstract><abstract id="ABS2" abstract-type="summary"><title>New &#x00026; Noteworthy</title><p id="P4">This paper established a protocol to maximize ketone body respiration in isolated brain mitochondria while quantifying acetyl-CoA and energy charge in control mice compared to mice with neuron-specific deletion of SCOT enzyme, required for ketone body oxidation. Findings are that alpha-ketoglutarate substantially increased AcAc-dependent respiration and neuron SCOT-KO had lower AcAc state 3 respiration with a decreased acetyl-CoA level.</p></abstract><abstract id="ABS3" abstract-type="graphical"><title>Graphical Abstract</title><p id="P5">
<graphic xlink:href="nihms-2076859-f0008.jpg" position="anchor"/>
</p></abstract><kwd-group><kwd>Brain</kwd><kwd>Ketone</kwd><kwd>Mitochondria respiration</kwd><kwd>SCOT</kwd></kwd-group></article-meta></front><body><sec id="S1"><title>Introduction</title><p id="P6">Studies investigating ketone metabolism as an alternative fuel source to enhance brain health and cognitive function in Alzheimer&#x02019;s disease, and to improve systemic metabolic health have increased over the last decade. During nutrient deprivation and limited carbohydrate availability, the liver catabolizes fatty acids and produces ketone bodies (KBs), which are then used by extrahepatic tissues as an alternative fuel, thus conserving limited glucose levels (<xref rid="R1" ref-type="bibr">1</xref>). Hepatic ketone synthesis, i.e., ketogenesis, includes producing acetoacetate (AcAc) and D-&#x003b2;-hydroxybutyrate (D-&#x003b2;OHB) from two acetyl-CoA molecules derived from &#x003b2;-oxidation of fatty acyl-CoAs. AcAc and D-&#x003b2;OHB are transported across the hepatocyte membranes via monocarboxylate transporters 1 and 2 (MCT1 and MCT2) into the blood and into extrahepatic tissues to meet the energy demands of anabolism and catabolism throughout the body (<xref rid="R2" ref-type="bibr">2</xref>). Specific to our studies with main focuses on brain energetics, when the brain is deprived of its preferred fuel source, glucose, ketone utilization is increased to meet metabolic demands (<xref rid="R3" ref-type="bibr">3</xref>). Ketogenic diets, which increase daily KB levels (low in carbohydrates and high in fat and protein) were first used to treat epileptic children (<xref rid="R4" ref-type="bibr">4</xref>). Further, they have been shown to improve several other central nervous system (CNS) disorders, including Alzheimer&#x02019;s disease (AD), Parkinson&#x02019;s disease, hypoxia, and traumatic brain injury (<xref rid="R4" ref-type="bibr">4</xref>) (<xref rid="R5" ref-type="bibr">5</xref>).</p><p id="P7">Beyond serving as an alternative fuel for the brain, KBs play many &#x0201c;non-canonical&#x0201d; signaling roles in maintaining cellular homeostasis, including protein posttranslational modification (PTM), and modulating inflammation or oxidative stress responses (<xref rid="R6" ref-type="bibr">6</xref>). Also, KB metabolism increases intracellular acetyl-CoA levels, which controls key cellular processes such as energy metabolism, autophagy, and mitosis (<xref rid="R7" ref-type="bibr">7</xref>). Despite numerous studies investigating ketones and metabolism, limited studies have examined respiration with KB as a primary substrate or changes in oxidative metabolites that result from KB-supported metabolism in mitochondria. This critical knowledge gap impacts research questions, including if KB respiration in the brain can be altered by different interventions such as fasting and exercise and if enhanced KB utilization improves metabolite sensing and signaling. Previous studies have measured KB respiration in neuronal cells (<xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref>) but only a few have measured KB supported respiration in isolated mitochondria from brain tissue (<xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R12" ref-type="bibr">12</xref>). Notably, these few studies have only measured KB respiration and only one previous study measured ADP-dependent KB supported mitochondrial respiration (<xref rid="R13" ref-type="bibr">13</xref>). Moreover, we are not aware of studies that have used chemical inhibitors to investigate the entry of reducing equivalents (electrons) from KBs into the electron chain transport (ETC).</p><p id="P8">Therefore, our first objective was to use Oroboros respirometry in isolated brain mitochondria to develop a methodology to maximize KB supported respiration rates. We compared &#x003b1;KG in the presence or absence of AcAc to explore if &#x003b1;KG would increase succinyl-CoA to drive forward the near equilibrium reaction of succinyl-CoA:3-oxoacidCoA transferase (SCOT) necessary to produce AcAc-CoA for terminal oxidation. Altogether, we established a protocol to directly measure the KB oxidative respiration rate in isolated brain mitochondria. Second, we tested if KB metabolism impacts resulting brain mitochondrial levels of acetyl CoA and energy charge. We then determined if neuron-specific deletion of the fate-committing step in ketone oxidation, SCOT, would reliably alter KB-supported respiratory responses and mitochondrial acetyl CoA and energy charge. Applying our protocol, we measured AcAc respiration in isolated brain mitochondria from SCOT control and SCOT-KO mice. After each experiment, we collected mitochondrial pellets from the respiratory chamber for metabolite and nucleotide concentration determination by mass spectrometry. Our results revealed a similar energy charge between SCOT control and SCOT-KO isolated mitochondria but a lower acetyl-CoA level in the mitochondria of the SCOT-KO than the control during respiration of AcAc.</p></sec><sec id="S2"><title>Materials and Methods</title><sec id="S3"><title>Ethical approval and experimental protocol</title><p id="P9">All animal use was in accordance with the National Institutes of Health (NIH) <italic toggle="yes">Guide for the care and use of laboratory animal</italic> and conformed to the principles specified in protocols approved by the University of Kansas Medical Center and University of Minnesota Institutional Animal Care and Use Committees (IACUC).</p></sec><sec id="S4"><title>Isolated Brain Mitochondria</title><p id="P10">Wild-type C57BL/6J male mice (8 &#x02013; 20 weeks of age) were fed <italic toggle="yes">ad libitum</italic> with a normal chow diet and housed on a 12:12 dark: light cycle. Neuron-specific SCOT knockout mice were developed by crossing the Synapsin 1-Cre driver to the floxed <italic toggle="yes">Oxct1</italic> allele on a C57BL/6NJ background (<xref rid="R14" ref-type="bibr">14</xref>). Wild-type C57BL/6J mice were used initially to establish the KB supported respiration protocol, with follow up studies focused on SCOT KO in C57BL/SNJ occurring separately. No between strain comparisons were performed. Mice were anesthetized and euthanized by phenobarbital injection and exsanguination followed by removal of the brain for isolation of mitochondria. The entire left hemisphere was transferred to pre-cooled glass Potter homogenizer with 8 mL of brain isolation buffer A (320 mM sucrose, 10 mM Tris-Cl, 1 mM EDTA, 2.5 g/L BSA). The tissue was homogenized with 4&#x02013;6 strokes at 200 rpms. The resulting homogenate was centrifuged for 10 min at 1,000 x g at 4&#x000b0;C. Then, the supernatant was transferred to a new tube and centrifuged for 10 min at 10,000 x g at 4&#x000b0;C. After centrifugation, the supernatant was discarded, the mitochondrial pellet was resuspended in 6 mL isolation buffer B (320 mM sucrose, 10 mM Tris-Cl, 1 mM EDTA) and recentrifuged for 10 min at 9,000 x g at 4 &#x000b0;C. Afterwards, the pellet was collected and resuspended in 1600 &#x003bc;L of isolation buffer B. Isolated brain mitochondria were stored on ice until use.</p></sec><sec id="S5"><title>KB Respiration Protocol in Isolated Brain Mitochondria</title><p id="P11">Respiration of isolated brain mitochondria was determined using Oxygraph-2k (O2k, OROBOROS Instruments, Innsbruck, Austria). Experiments using isolated brain mitochondria from wild type C57BL/6J male mice were performed in modified MiR05 (110 mM sucrose; 60 mM K-MES; 0.5 mM EGTA; 3 mM MgCl<sub>2</sub>; 10 mM KH<sub>2</sub>PO<sub>4</sub>; 20 mM HEPES; 0.1% fatty acid-free BSA; and 20 mM glucose; adjusted to pH 7.1 with KOH). All experiments were performed at 37&#x025e6;C. 75&#x02013;100 &#x003bc;g of mitochondria in buffer (25&#x02013;30 &#x003bc;L) were added to each 2-ml respiration chamber. Substrate concentrations for respirometry experiment are shown as following: 2 mM Malate; 0.01 mM CoA; 2.5 mM Carnitine; 10 mM ADP; 1 mM &#x003b1;KG; 1 mM AcAc; 1 mM D-&#x003b2;OHB. Since KBs putatively provide reducing agents to both complex I and II, we investigated the entry path of electrons from KBs to the ETC, leveraging malonic acid (5 mM Mna, complex II inhibitor) and rotenone (0.002 mM Rot, complex I inhibitor). Following all respirometry experiments, data was normalized to the mitochondrial protein via BCA assay. Acetoacetate was synthesized as previously described (<xref rid="R15" ref-type="bibr">15</xref>). Briefly, ethyl acetoacetate underwent base-catalyzed hydrolysis using an equimolar amount of sodium hydroxide at 60&#x000b0;C, followed by neutralization with HCl, sterile filtration and storage at &#x02212;80&#x000b0;C. Chemical purity was assessed via <sup>1</sup>H-NMR and concentration was quantified via UHPLC-MS/MS.</p></sec><sec id="S6"><title>Ketone Supported Respiration in SCOT Control and SCOT-KO</title><p id="P12">30&#x02013;32 weeks old C57BL/6NJ SCOT-Control and neuron-specific SCOT-KO male mice were placed on a reverse light cycle (dark 10:00 &#x02212;22:00), with <italic toggle="yes">ad libitum</italic> assess to water and normal chow diet. We used 30&#x02013;32-week-old middle-aged mice as metabolism changes are often noticed of the middle-aged brain (<xref rid="R16" ref-type="bibr">16</xref>), to explore the ability of neuron cells to oxidize ketone bodies and determine the effects of ketone oxidation on acetyl CoA and energy charge in isolated brain mitochondria. Brain mitochondria were isolated as above, protein concentration determined by BCA, and 150 ug of mitochondrial protein was used. Respiration experiments were performed in the same modified MiR05 buffer as above at 37&#x025e6;C and substrate concentrations were the same as above. Briefly, following additions of different fuel substrates, brain mitochondria were added, and a baseline respiration value was reached. The respiratory flux was then assessed following sequential adding substrates. After each respiration experiment, contents of the reaction wells were transferred to microcentrifuge tubes and centrifuged at 8,000 x g at 4&#x000b0;C for 15 minutes. The supernatant was discarded, and the pellet was collected and frozen in liquid nitrogen and stored at &#x02212;80 &#x000b0;C until processing.</p></sec><sec id="S7"><title>Acetyl CoA and energy charge analysis in isolated brain mitochondria via LC-MS/MS.</title><p id="P13">Mitochondria were homogenized using pestle with cold 0.4 M perchloric acid, 0.5 mM EGTA extraction solution containing [ <sup>13</sup>C<sub>10</sub>, <sup>15</sup>N<sub>5</sub>] ATP sodium salt (100 mM), [<sup>13</sup>C<sub>10</sub>, <sup>15</sup>N<sub>5</sub>] AMP sodium salt (100 mM), [1,2-<sup>13</sup>C<sub>2</sub>] acetyl-CoA lithium salt (5 mM), and [1,2,3-<sup>13</sup>C<sub>3</sub>] malonyl-CoA lithium salt (5 mM) purchased from Sigma. After incubation on ice for 10 min, samples were centrifuged at 15,000xg for 15 min at 4&#x02070;C. The resulting supernatants were neutralized with freshly prepared 0.5 M K<sub>2</sub>CO<sub>3</sub>, vortexed, and centrifuged at 15,000xg for 30 min at 4&#x02070;C. Final extracts were then analyzed by LC-MS/MS as previously described, with modifications (<xref rid="R17" ref-type="bibr">17</xref>). Briefly, analysis of energy acetyl CoA and energy charge was performed using a Vanquish LC system. Separation was achieved on a reverse-phase C18 column (Waters Xbridge, 150 &#x000d7; 2.1 mm, 3.5 &#x003bc;m) using the following mobile phases: A) 95% water/5% methanol with 4 mM dibutylammonium acetate (DBAA, Millipore Sigma) and B) 25% water/75% acetonitrile with 4 mM DBAA. The ion-pairing mobile phase additive DBAA provided adequate chromatographic separation. Samples were separated using the following binary gradients: 0&#x02013;80% B for 8 min, 80&#x02013;100% B for 5 min, 100% B for 3 min, and 100&#x02013;0% B for 5 min. The flow rate was 100 &#x003bc;L/min, with a diverter valve used for the first 2 min to minimize matrix components entering the MS. The column was maintained at 30&#x02070; C and the injection volume was 2 &#x003bc;L. The LC system was hyphenated to a Thermo Q Exactive Plus MS equipped with heated electrospray ionization. The MS was operated in positive ionization mode with PRM mode used for quantitatively targeted analysis. The isolation window was set to m/z 1.0; the resolution was 17,500, and the collision energy was 35 (arbitrary units). Retention times and m/z transitions for acetyl CoA are detailed in <bold>Supplemental_Table_1.</bold> (DOI: <ext-link xlink:href="10.6084/m9.figshare.28653461" ext-link-type="doi">10.6084/m9.figshare.28653461</ext-link>). Energy charge was calculated from the concentration of quantified nucleotides using the following formula: Energy Charge = ([ATP] + 0.5[ADP]) / ([ATP] + [ADP] + [AMP]). (<xref rid="R18" ref-type="bibr">18</xref>)</p></sec><sec id="S8"><title>Statistical Analysis</title><p id="P14"><xref rid="F1" ref-type="fig">Fig. 1</xref>, <xref rid="F2" ref-type="fig">Fig. 2</xref> and <xref rid="F3" ref-type="fig">Fig. 3A</xref>&#x00026;<xref rid="F3" ref-type="fig">B</xref> were analyzed using one-way ANOVA, followed by a Fisher&#x02019;s LSD post hoc analysis. <xref rid="F3" ref-type="fig">Fig. 3C</xref> was analyzed using unpaired <italic toggle="yes">t</italic> test to directly compare AcAc vs D-&#x003b2;OHB supported induction of respiration. In <xref rid="F4" ref-type="fig">Fig. 4E</xref>, <xref rid="F5" ref-type="fig">Fig. 5</xref>, and <xref rid="F6" ref-type="fig">Fig. 6</xref>, unpaired <italic toggle="yes">t</italic> test was used to examine SCOT control and SCOT KO under different substrate conditions. For <xref rid="F4" ref-type="fig">Fig. 4B</xref>, <xref rid="F4" ref-type="fig">4D</xref> and <xref rid="F4" ref-type="fig">4F</xref>, the effect of genotype, substrates and their interaction were analyzed by a two-way ANOVA analysis, followed by a Fisher&#x02019;s LSD post hoc analysis. All data are presented as means &#x000b1; SEM and outliers are removed using Grubbs&#x02019; test. Statistical significance was defined as <italic toggle="yes">P &#x0003c;</italic> 0.05, and all statistics were run using GraphPad Prism 10.0 (GraphPad Software Inc., La Jolla, CA).</p></sec></sec><sec id="S9"><title>Results</title><sec id="S10"><title>KBs alone minimally drive respiration in brain mitochondria.</title><p id="P15">We determined maximal ADP-dependent respiration of isolated brain mitochondria from Wild-type C57BL/6J male mice in response to increasing concentrations of AcAc (0.1 &#x02013;10 mM, <xref rid="F1" ref-type="fig">Fig. 1A</xref>). Respiration of AcAc only increased above basal by 15% at a concentration ranging from 0.1 to 0.5 mM, decreasing after a concentration of 1 mM, and continued to decrease to 10 mM (~20&#x02013; 35% less than basal at 8 mM: <xref rid="F1" ref-type="fig">Fig. 1B</xref>). In contrast to other metabolic substrates, KB metabolism provides a surplus flux of acetyl-CoA (<xref rid="R19" ref-type="bibr">19</xref>). Other studies have shown AcAc alone inhibited &#x003b1;-ketoglutarate dehydrogenase activity due to sequestration of free CoASH which inhibits KB utilization (<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>). L-carnitine is another essential molecule involved in fatty acid metabolism that transports fatty acid chains into the mitochondrial matrix for utilization (<xref rid="R22" ref-type="bibr">22</xref>). Thus, we tested if low KB-supported respiration rate in brain mitochondria was due to the low availability of CoASH and carnitine. Since D-&#x003b2;OHB is upstream of AcAc oxidation and generates reducing equivalents as NADH, we added D-&#x003b2;OHB (1 mM) to examine if the extra step in breakdown is impacted by various treatments (<xref rid="F1" ref-type="fig">Fig. 1C</xref>). Again, KB supported respiration rates in the isolated brain mitochondria were low: 5&#x02013;10% increase for AcAc and 35%&#x02212;40% increase for D-&#x003b2;OHB (<xref rid="F1" ref-type="fig">Fig. 1D</xref>). This increase with D-&#x003b2;OHB may contribute to the production of NADH via &#x003b2;OHB dehydrogenase. Overall, our findings indicate that KB respiration in isolated mitochondria is relatively low when considering respiration rates of other mitochondrial substrates (<xref rid="R23" ref-type="bibr">23</xref>).</p></sec><sec id="S11"><title><italic toggle="yes">&#x003b1;</italic>-ketoglutaric acid enhances respiration of AcAc.</title><p id="P16">Given the modest KB supported respiration rate after addition of CoASH and carnitine, we hypothesized that other substrates were needed for maximal mitochondrial KB respiration. Ketone body oxidation requires activation of AcAc by succinyl-CoA to generate AcAc-CoA through the activity of SCOT. Thiolytic cleavage of AcAc-CoA generates acetyl-CoA that enters the TCA cycle for terminal oxidation. Succinyl-CoA is generated from &#x003b1;KG in the presence of free CoASH by &#x003b1;-ketoglutarate dehydrogenase. However, the common addition of malate to mitochondrial respiration experiments depletes endogenous &#x003b1;KG by antiport with malate via the malate-aspartate shuttle, potentially limiting mitochondrial succinyl-CoA availability for AcAc activation via the SCOT reaction. Therefore, we posited that KB respiration in isolated mitochondrial requires supplementation of succinyl-CoA. To test this, we added &#x003b1;KG to our respiration protocol (<xref rid="F2" ref-type="fig">Fig. 2A</xref>), expecting that it would increase succinyl-CoA and enhance KB respiration (<xref rid="F1" ref-type="fig">Fig. 1E</xref>). Compared to adding AcAc alone (respiration 5&#x02013;10% increase to basal: <xref rid="F1" ref-type="fig">Fig. 1D</xref>), adding AcAc following the addition &#x003b1;KG increases AcAc respiration 75% higher than basal (<xref rid="F2" ref-type="fig">Fig. 2B</xref>). To determine the KB concentration for maximal mitochondrial respiration in the presence of &#x003b1;KG, we again performed a titration of AcAc (<xref rid="F2" ref-type="fig">Fig. 2C</xref>). Dose-dependent increase of AcAc respiration was observed up to 1 mM AcAc, with decreases observed at higher concentrations (<xref rid="F2" ref-type="fig">Fig. 2D</xref>). Increasing &#x003b1;KG concentrations failed to augment AcAc respiration further (<xref rid="F2" ref-type="fig">Fig. 2E</xref>&#x02013;<xref rid="F2" ref-type="fig">F</xref>). To determine the extent to which succinyl-CoA synthetase-derived succinate drove the effect of &#x003b1;KG on respiration, we used malonic acid, a complex II (succinate dehydrogenase) inhibitor, which diminished &#x003b1;KG-dependent respiration only by 15% suggesting that &#x003b1;KG sourcing of succinyl-CoA synthetase-derived succinate was a minor contributor (<xref rid="F2" ref-type="fig">Fig. 2G</xref>&#x02013; <xref rid="F2" ref-type="fig">H</xref>). This suggests the &#x003b1;KG effect is primarily complex I-dependent, via &#x003b1;KG dehydrogenase-dependent NADH and succinyl-CoA. In summary, our experiments show that &#x003b1;KG at 1 mM drives maximal respiration of AcAc. Finally, the addition of &#x003b1;KG likely resulted in significant complex I-mediated respiration.</p></sec><sec id="S12"><title>Comparative respiration of AcAc and D-<italic toggle="yes">&#x003b2;</italic>OHB in isolated brain mitochondria.</title><p id="P17">Since KBs putatively provide reducing agents to both complex I and II (<xref rid="R24" ref-type="bibr">24</xref>), we next investigated the entry path of electrons from KBs to the ETC using the protocol shown in <xref rid="F3" ref-type="fig">Fig. 3A</xref>, leveraging malonic acid (Mna, complex II inhibitor) and rotenone (Rot, complex I inhibitor). Again, we observed increased respiration after the addition of AcAc and D-&#x003b2;OHB compared to &#x003b1;KG alone (<xref rid="F3" ref-type="fig">Fig. 3B</xref>&#x00026;<xref rid="F3" ref-type="fig">3C</xref>). We then calculated this increased respiration using the respiration of &#x003b1;KG alone and after the addition of KBs (Respiration <sub>(&#x003b1;KG +AcAc or D-&#x003b2;OHB)</sub> - Respiration <sub>(&#x003b1;KG)</sub>) (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). We found no significant difference in respiration rates fueled by AcAc or D-&#x003b2;OHB (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). <xref rid="F3" ref-type="fig">Fig. 3D</xref> directly compares AcAc vs. D-&#x003b2;OHB supported induction of respiration (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). A complex I inhibitor, rotenone (Rot), was added and elicited a bigger decrease than Mna for both substrates (<xref rid="F3" ref-type="fig">Fig. 3B</xref>&#x00026;<xref rid="F3" ref-type="fig">3C</xref>), suggesting that &#x003b1;KG +KB respiration are complex I driven via &#x003b1;KG dehydrogenase and D-&#x003b2;OHB dehydrogenase (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). To our surprise, Mna resulted in a bigger decrease in D-&#x003b2;OHB supported respiration compared to respiration with AcAc in isolated brain mitochondria, suggesting that D-&#x003b2;OHB was more complex II driven than AcAc via succinate (<xref rid="F3" ref-type="fig">Fig. 3D</xref>). In summary, our findings suggest that &#x003b1;KG is necessary for maximizing KB respiration in isolated brain mitochondria and KBs contribute to ETC mainly through complex I, however, D-&#x003b2;OHB contributes more to complex II than AcAc.</p></sec><sec id="S13"><title>AcAc respiration requires SCOT.</title><p id="P18">As previously stated, ketone utilization is regulated by SCOT mediated covalent activation of AcAc by succinyl-CoA to form AcAc-CoA, which is converted to acetyl-CoA for entry into the TCA cycle (<xref rid="R14" ref-type="bibr">14</xref>). Since AcAc is downstream of D-&#x003b2;OHB and focusing on the regulating step: the exchange between succinyl-CoA and AcAc via SCOT, we compared how control mice vs. SCOT-KO would respire with AcAc as a substrate and if loss of SCOT would differently impact metabolite pools within brain mitochondria. Since neuronal cells display high energy demand (<xref rid="R25" ref-type="bibr">25</xref>), we suspected that the lack of SCOT in neurons would impair AcAc respiration rate. Importantly however, mitochondria isolated from brain includes neuronal and non-neuronal sources including astrocytes and oligodendrocytes that still express the SCOT enzyme (<xref rid="R26" ref-type="bibr">26</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref>). First, we tested if &#x003b1;KG was essential for AcAc respiration in middle-aged control and SCOT KO C57BL/6NJ mice (30&#x02013;32 weeks) (<xref rid="F4" ref-type="fig">Fig. 4</xref>) and again showed that without &#x003b1;KG there was a modest minimal AcAc respiration (<xref rid="F5" ref-type="fig">Fig. 5A</xref>&#x00026;<xref rid="F4" ref-type="fig">4B</xref>). No significant differences were noticed between the control and KO when comparing mitochondrial alone respiration and AcAc respiration. We then tested if AcAc would increase &#x003b1;KG respiration (<xref rid="F5" ref-type="fig">Fig. 5C</xref>). Both control and KO demonstrated significant increase in respiration <sub>(&#x003b1;KG +AcAc)</sub> compared to the respiration with &#x003b1;KG alone (2-fold increase (WT) and 68% increase (KO) to basal) (<xref rid="F5" ref-type="fig">Fig. 5D</xref>). No significant difference was observed in respiration <sub>(&#x003b1;KG)</sub> between the control and KO but there was a significant decrease in SCOT KO respiration <sub>(&#x003b1;KG +AcAc)</sub> (Respiration 14.7% lower in SCOT KO to control). Since mitochondria were isolated from the whole left hemisphere of the brain and SCOT was eliminated only in neurons, we suspected residual AcAc respiration from other cell types but that a small decrease in AcAc respiration was attributable to lacking SCOT in neurons. As expected, controls showed a significantly higher AcAc respiration (Respiration <sub>(&#x003b1;KG +AcAc)</sub> - Respiration <sub>(&#x003b1;KG)</sub>) than SCOT-KO (<xref rid="F5" ref-type="fig">Fig. 5E</xref>). We then used Rot and Mna in separate respiration experiments to distinguish how AcAc contributes to Complex I and Complex II, respectively. Like what we observed before, adding Rot had a larger inhibition of respiration than Mna, indicating respiration <sub>(&#x003b1;KG +AcAc)</sub> was predominantly supported by complex I (<xref rid="F5" ref-type="fig">Fig. 5F</xref>). However, no significant difference was notable between the control and KO in AcAc contribution to complex I or complex II (<xref rid="F5" ref-type="fig">Fig. 5F</xref>). Again, maintenance of AcAc respiration in neuronal SCOT KO mitochondria is likely due to maintenance of SCOT expression in mitochondria isolated from other cell types in the brain.</p></sec><sec id="S14"><title>Metabolite levels and energy charge in isolated brain mitochondria fueled with AcAc.</title><p id="P19">Previously, KB metabolism has been shown to affect metabolite pools within various tissues that use KB as their fuel source (<xref rid="R7" ref-type="bibr">7</xref>). With neurons being the biggest energy consumer, we expected that lacking ketolysis in neurons would influence brain mitochondria metabolite profile. Providing brain mitochondria from the control and SCOT-KO with AcAc, we quantified the metabolite contents such as acetyl-CoA and calculated energy charge (EC) from ADP, AMP and ATP (<xref rid="R18" ref-type="bibr">18</xref>) with mass spectrometry. Energy charge is defined as (ATP+0.5 ADP)/(ATP+ADP+AMP), which is a measure of the relative concentrations of substrates and products of ATP-generating and ATP-utilizing reactions (<xref rid="R18" ref-type="bibr">18</xref>). Since &#x003b1;KG is the co-substrate for maximizing AcAc respiration, we first evaluated the metabolite contents in the control and SCOT-KO with 1 mM of &#x003b1;KG. A larger quantity of brain mitochondria (150 &#x003bc;g) was used for a more accurate measurement of acetyl CoA and energy charge (<xref rid="F4" ref-type="fig">Fig. 4</xref>). We again used Mna and Rot to examine the impacts of &#x003b1;KG on our experimental conditions (<xref rid="F6" ref-type="fig">Fig. 6A</xref>). At the end of each respiration experiment, we measured respiration rate, and it showed no significant difference between the control and KO under following conditions: &#x003b1;KG, &#x003b1;KG+Mna, &#x003b1;KG+Rot (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). Comparing respiration rate among three conditions, inhibiting complex I reduced the respiration rate (&#x003b1;KG+Rot) greater than complex II (&#x003b1;KG+Mna) (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). It again suggested that &#x003b1;KG was primarily complex I driven via &#x003b1;KG dehydrogenase which produces NADH. We then measured metabolite substrates: acetyl CoA and calculated energy charge using AMP, ADP, and ATP (<xref rid="R18" ref-type="bibr">18</xref>). Again, the control and KO showed no significant difference (<xref rid="F6" ref-type="fig">Fig. 6D</xref>&#x00026;<xref rid="F6" ref-type="fig">6E</xref>).</p><p id="P20">To determine the role of neuronal SCOT in AcAc-dependent changes in acetyl-CoA and energy charge, we used AcAc and &#x003b1;KG+AcAc to test any differences between the control and KO (<xref rid="F7" ref-type="fig">Fig. 7A</xref>). Complex I and II inhibitors were added to examine the flow of electrons from &#x003b1;KG+AcAc to the ETC within mitochondria. The mitochondrial respiration status showed no difference between the control and KO despite trends for lower respiration in KO without inhibitors and with Rot (<xref rid="F7" ref-type="fig">Fig. 7B</xref>). As expected for &#x003b1;KG+AcAc, acetyl-CoA levels were significantly decreased in the SCOT-KO across the three conditions, suggesting that diminished procession from AcAc to acetyl-CoA on brain mitochondria in which SCOT had been eliminated from neurons (<xref rid="F7" ref-type="fig">Fig. 7C</xref>). This diminished acetyl-CoA pool phenotype are dependent on both &#x003b1;KG and AcAc and not seen in either &#x003b1;KG alone (<xref rid="F6" ref-type="fig">Fig. 6C</xref>) or AcAc alone (<xref rid="F7" ref-type="fig">Fig. 7C</xref>). Again, it suggests &#x003b1;KG as a source of succinyl-CoA for the procession from AcAc to acetyl-CoA. Mitochondrial energy charge was not different between the control and KO (<xref rid="F7" ref-type="fig">Fig. 7D</xref>).</p></sec></sec><sec id="S15"><title>DISCUSSION</title><p id="P21">While brain ketone metabolism has been examined for decades, limited studies have focused on direct KB mitochondrial respiration, leaving a methodological gap that limits understanding. Previous studies have shown neuronal cell KB respiration (<xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref>) and other studies have also investigated how mitochondria from skeletal muscle (isolated mitochondria and permeabilized fibers) respire with ketone bodies as a primary substrate, revealing minimal increases in ADP-dependent respiratory rates (<xref rid="R13" ref-type="bibr">13</xref>). These findings do not track with the known capacity of ketone bodies to fuel metabolic tissues, suggesting a methodological gap for measuring KB supported respiration. To address this gap, we developed a new respiration protocol to maximize KB respiration in isolated brain mitochondria. Our findings suggest that mitochondrial respiration is minimally supported by AcAc alone but that the addition of &#x003b1;KG before AcAc allows for the accumulation of succinyl-CoA, which drives the reaction forward, increasing respiration with both AcAc and D-&#x003b2;OHB in mice isolated brain mitochondria. Furthermore, our findings using complex II inhibitor (malonic acid) suggests that D-&#x003b2;OHB substrate contributes more electrons to complex II via succinate than AcAc but that both substrates primarily rely on complex I for respiration. We also showed mice with neuronal-specific deletion of succinyl-CoA transferase (SCOT) had lower KB-supported respiration than control mice but did not display differences in mitochondrial energy charge despite decreased acetylCoA levels when AcAc was used as the substrate.</p><p id="P22">Our results suggest that &#x003b1;KG should be an addition to future studies examining KB respiration in metabolic tissues. The biochemistry of these effects is linked to succinyl-CoA availability driving forward a key near-equilibrium equation (SCOT) in ketone metabolism. &#x003b1;KG dehydrogenase converts &#x003b1;KG to succinyl-CoA via decarboxylation and succinyl-CoA is required for the conversion of AcAc to Acetoacetyl-CoA by the SCOT enzyme, an essential step in KBs utilization. AcAc is converted to AcAc-CoA via an equilibrium reaction catalyzed by succinyl-CoA through a CoA exchange with succinyl-CoA. Hydrolysis of AcAc-CoA releases more free energy than succinyl-CoA, favoring AcAc formation (<xref rid="R30" ref-type="bibr">30</xref>). Adding &#x003b1;KG and increasing succinyl-CoA pulls AcAc toward the AcAc-CoA fate. SCOT-derived AcAc-CoA produces two acetyl-CoA which then enters the TCA cycle for final oxidation (<xref rid="R30" ref-type="bibr">30</xref>). As expected from our hypothesis, the addition of &#x003b1;KG as a co-substrate maximized KB-supported respiration, but the maximal effect was reached at 1 mM of &#x003b1;KG. However, adding &#x003b1;KG may also drive up the production of succinyl-CoA which furnishes TCA cycle&#x02019;s succinyl-CoA synthetase with a substrate generating ATP (GTP) and succinate. &#x003b1;KG-driven respiration is approximately 15% complex II-dependent (<xref rid="F2" ref-type="fig">Fig. 2H</xref>) suggesting the engagement of succinyl-CoA synthetase to produce succinate, a complex II related substrate. The production of ATP could potentially affect ATP synthesis via decreasing &#x00394;G-ATP. However, this is likely not relevant in ADP abundant conditions (State 3). In addition, the accumulation of succinate could potentially inhibit SCOT enzymes capacity to produce AcAc-CoA + succinate, which could explain why increasing &#x003b1;KG concentration above 1 mM does provide no further increase AcAc supported respiration. Again, it suggests 1 mM &#x003b1;KG maximizing AcAc-CoA production with the least inhibition from succinate. Other studies have shown that under the presence of complex I inhibition by rotenone, D-&#x003b2;OHB improves oxygen consumption via complex II (<xref rid="R31" ref-type="bibr">31</xref>) but no studies have directly compared D-&#x003b2;OHB with AcAc and its electron contribution to complex II. The addition of complex I inhibitor after inhibiting complex II completely eradicates the remaining mitochondrial respiration, suggesting there is no &#x0201c;extra mitochondrial&#x0201d; source of respiration in mitochondria isolated from brain tissue. Comparing the decrease induced by complex I inhibitor with complex II inhibitor, our results show that both AcAc and D-&#x003b2;OHB primarily contribute electrons through complex I via production of NADH. Surprisingly, Mna resulted in a bigger drop in D-&#x003b2;OHB compared to AcAc, suggesting that D-&#x003b2;OHB was more complex II driven than AcAc via succinate. D-&#x003b2;OHB should generate more NADH (Complex I substrate) via &#x003b2;OHB dehydrogenase, and thus, relative to AcAc, less of its JO2 should be attributable to Complex II. These results might be occurring due to adding &#x003b1;KG as a co-substrate prior to the addition of AcAc or D-&#x003b2;OHB. Further studies are needed to investigate the entry path of electrons into the ETC with only D-&#x003b2;OHB and leveraging both malonic acid (Mna, complex II inhibitor) and rotenone (Rot, complex I inhibitor). As expected, increasing AcAc concentrations greater than 1 mM tended to decrease <italic toggle="yes">J</italic>O<sub>2</sub>. This could be partially attributable to free CoASH sequestration-mediated inhibition of substrate activation. Moreover, acetyl-CoA accumulation at higher AcAc concentrations inhibit citrate synthase (<xref rid="R32" ref-type="bibr">32</xref>).</p><p id="P23">Besides being known as the energy source in the fasting state, KB are also heavily studied for signaling functions. Studies have shown that &#x003b2;OHB can function as a ligand for different G-protein coupled receptors to reduce lipolysis, reduce sympathetic tone, and lower metabolic rate (<xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>). Less is known about how ketone utilization affects metabolite contents within mitochondria. Metabolites emanating from ketone metabolism likely regulate multiple mitochondrial signaling pathways and may provide an underlying context to the benefits of brain ketone metabolism (<xref rid="R1" ref-type="bibr">1</xref>). Here, we used the ketone respiration protocol we developed earlier and compared how control mice with Neuron-SCOT present vs. Neuron-SCOT KO differ in their acetyl CoA levels and energy status after providing AcAc as a fuel source. In the adult brain, neurons have the highest energy demand, and by knocking out the key enzyme SCOT for ketone utilization, we blunt neuronal ability to utilize AcAc, thus allowing us to test if significant changes in neuronal ketone utilization alter metabolite levels and energy charge. Since we used the entire half of the left hemisphere, we would expect residual ketone-supported respiration by other cell types that express SCOT but a decrease in ketone-supported respiration due to the absence of SCOT in neurons. Aligning with our hypothesis, we noticed a decline in AcAc-supported respiration in the SCOT-Neuron KO compared to the control. We observed an overall decrease in acetyl-CoA level in the SCOT-Neuron KO mitochondria using AcAc+&#x003b1;KG as the substrate. Mounting evidence has shown that exogenous KB leads to increased levels of acetyl-CoA and the citric cycle intermediates in the brain (<xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R35" ref-type="bibr">35</xref>). The compromised neuronal ability to utilize AcAc in the SCOT-KO leads to lower production of acetyl-CoA, which might explain the overall decrease seen in SCOT-KO. However, this difference between the control and KO was not seen when AcAc alone was used (<xref rid="F7" ref-type="fig">Fig. 7C</xref>). This again suggests that &#x003b1;KG is an essential co-substrate for AcAc to be metabolized in brain mitochondria. One limitation for measuring acetyl-CoA level in isolated mitochondria is the possibility of acetyl-CoA being exported out of the mitochondria as acetyl-carnitine during the isolation process, thus the acetyl CoA levels reported here may not truly reflect levels in mitochondria in vivo. Interestingly, we also observed a disconnect of no significant differences in final respiration but lower acetyl-CoA level. This might be because acetyl-CoA was in excess and not a limitation in fueling the TCA cycle to fuel forward the respiration reaction.</p><p id="P24">We also measured AMP, ADP, and ATP concentration to calculate energy charge in isolated brain mitochondria following the respiration protocol in the O2k. Our results showed no significant difference in energy charge between WT and KO regardless of substrate conditions. Under physiological conditions, the energy charge value fluctuates around 0.75&#x02013;0.90, stabilizing around 0.9 (<xref rid="R36" ref-type="bibr">36</xref>). In our case, mitochondrial energy charge was around 0.5 between WT and KO, indicating ATP depletion. This shift could be explained by mitochondrial shifting to a lower EC when its surrounding conditions are unfavorable, such as isolation from the in vivo environment.</p><p id="P25">Our study has other limitations. While we focused on ketone respiration in isolated brain mitochondria, ketone bodies enter cells via MCTs (MCT1 and MCT2) (<xref rid="R2" ref-type="bibr">2</xref>), a regulatory node ignored in isolated mitochondria. In addition, there is evidence that mitochondria exist in a reticulum in neurons and glia cells. Thus, the mitochondrial isolation process would disrupt the reticulum, and thus, we are quantifying respiration in mitochondria not truly representative of their morphology in-vivo (<xref rid="R37" ref-type="bibr">37</xref>).</p><p id="P26">In summary, the protocol and substrate conditions described above allows for a direct and enhanced measurement of maximal KB-supported respiration in isolated brain mitochondria which will allow for future studies to investigate if and how brain mitochondria adjust to various interventions (ketogenic diets, intermittent fasting, exercise) or pathological states that may alter hepatic ketogenic production and utilization rates in the brain. Adding &#x003b1;KG enhances ketone-supported respiration, enabling us to quantify better oxidative phosphorylation in brain mitochondria utilizing ketones. This method is meant to serve as a base platform upon which new modules can be tailored to expand its usage in other tissues, such as the heart, muscle, and kidney, expanding our capacity to understand ketone metabolism in mitochondria in relation to whole-body effects. We also demonstrate that neuronal loss of SCOT reduces acetyl CoA levels in isolated brain mitochondria compared to controls, but does not change energy charge, and only slightly lowers respiration in whole brain isolated mitochondria. Furthermore, the detailed analysis of acetyl CoA and energy status in isolated brain mitochondria following respiration is also a new method that provides a tool for relating respiratory results to mitochondrial fuel sources and energy status. Overall, our newly described substrate conditions for measuring KB-supported respiration set the stage for further work exploring the novel therapeutic potentials of ketone metabolism.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><p id="P27">Supplemental_Table_1. (DOI link: <ext-link xlink:href="10.6084/m9.figshare.28653461" ext-link-type="doi">10.6084/m9.figshare.28653461</ext-link>)</p></sec></body><back><ack id="S16"><title>Acknowledgement</title><p id="P28">The graphical abstract was created using bioRender (<ext-link xlink:href="https://biorender.com/" ext-link-type="uri">https://BioRender.com</ext-link>).</p><sec id="S17"><title>Grants</title><p id="P29">This word was supported by NIH grants S10 OD028598 (JPT), K01DK112967 (EMM), P20GM144269 (EMM and JPT), HL166142 (EDQ), and R01AG069781 (JPT and PAC).</p></sec></ack><fn-group><fn fn-type="COI-statement" id="FN3"><p id="P31">Disclosures</p><p id="P32">The authors declare no conflicts of interest.</p></fn></fn-group><sec sec-type="data-availability" id="S18"><title>Data Availability</title><p id="P30">All data will be made available upon request.</p></sec><ref-list><title>Reference List</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Jensen</surname><given-names>NJ</given-names></name>, <name><surname>Wodschow</surname><given-names>HZ</given-names></name>, <name><surname>Nilsson</surname><given-names>M</given-names></name>, and <name><surname>Rungby</surname><given-names>J</given-names></name>. <article-title>Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases</article-title>. <source>Int J Mol Sci</source>
<volume>21</volume>: <year>2020</year>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Puchalska</surname><given-names>P</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics</article-title>. <source>Cell Metab</source>
<volume>25</volume>: <fpage>262</fpage>&#x02013;<lpage>284</lpage>, <year>2017</year>.<pub-id pub-id-type="pmid">28178565</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Manninen</surname><given-names>AH</given-names></name>. <article-title>Metabolic effects of the very-low-carbohydrate diets: misunderstood &#x0201c;villains&#x0201d; of human metabolism</article-title>. <source>J Int Soc Sports Nutr</source>
<volume>1</volume>: <fpage>7</fpage>&#x02013;<lpage>11</lpage>, <year>2004</year>.<pub-id pub-id-type="pmid">18500949</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Pietrzak</surname><given-names>D</given-names></name>, <name><surname>Kasperek</surname><given-names>K</given-names></name>, <name><surname>Rekawek</surname><given-names>P</given-names></name>, and <name><surname>Piatkowska-Chmiel</surname><given-names>I</given-names></name>. <article-title>The Therapeutic Role of Ketogenic Diet in Neurological Disorders</article-title>. <source>Nutrients</source>
<volume>14</volume>: <year>2022</year>.</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Daines</surname><given-names>SA</given-names></name>. <article-title>The Therapeutic Potential and Limitations of Ketones in Traumatic Brain Injury</article-title>. <source>Front Neurol</source>
<volume>12</volume>: <fpage>723148</fpage>, <year>2021</year>.<pub-id pub-id-type="pmid">34777197</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Nelson</surname><given-names>AB</given-names></name>, <name><surname>Queathem</surname><given-names>ED</given-names></name>, <name><surname>Puchalska</surname><given-names>P</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Metabolic Messengers: ketone bodies</article-title>. <source>Nat Metab</source>
<volume>5</volume>: <fpage>2062</fpage>&#x02013;<lpage>2074</lpage>, <year>2023</year>.<pub-id pub-id-type="pmid">38092961</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Pietrocola</surname><given-names>F</given-names></name>, <name><surname>Galluzzi</surname><given-names>L</given-names></name>, <name><surname>Bravo-San Pedro</surname><given-names>JM</given-names></name>, <name><surname>Madeo</surname><given-names>F</given-names></name>, and <name><surname>Kroemer</surname><given-names>G</given-names></name>. <article-title>Acetyl coenzyme A: a central metabolite and second messenger</article-title>. <source>Cell Metab</source>
<volume>21</volume>: <fpage>805</fpage>&#x02013;<lpage>821</lpage>, <year>2015</year>.<pub-id pub-id-type="pmid">26039447</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Koppel</surname><given-names>SJ</given-names></name>, <name><surname>Wilkins</surname><given-names>HM</given-names></name>, <name><surname>Weidling</surname><given-names>IW</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Menta</surname><given-names>BW</given-names></name>, and <name><surname>Swerdlow</surname><given-names>RH</given-names></name>. <article-title>beta-Hydroxybutyrate preferentially enhances neuron over astrocyte respiration while signaling cellular quiescence</article-title>. <source>Mitochondrion</source>
<volume>68</volume>: <fpage>125</fpage>&#x02013;<lpage>137</lpage>, <year>2023</year>.<pub-id pub-id-type="pmid">36516926</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Llorente-Folch</surname><given-names>I</given-names></name>, <name><surname>Dussmann</surname><given-names>H</given-names></name>, <name><surname>Watters</surname><given-names>O</given-names></name>, <name><surname>Connolly</surname><given-names>NMC</given-names></name>, and <name><surname>Prehn</surname><given-names>JHM</given-names></name>. <article-title>Ketone body beta-hydroxybutyrate (BHB) preserves mitochondrial bioenergetics</article-title>. <source>Sci Rep</source>
<volume>13</volume>: <fpage>19664</fpage>, <year>2023</year>.<pub-id pub-id-type="pmid">37952048</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Perez-Liebana</surname><given-names>I</given-names></name>, <name><surname>Casarejos</surname><given-names>MJ</given-names></name>, <name><surname>Alcaide</surname><given-names>A</given-names></name>, <name><surname>Herrada-Soler</surname><given-names>E</given-names></name>, <name><surname>Llorente-Folch</surname><given-names>I</given-names></name>, <name><surname>Contreras</surname><given-names>L</given-names></name>, <name><surname>Satrustegui</surname><given-names>J</given-names></name>, and <name><surname>Pardo</surname><given-names>B</given-names></name>. <article-title>betaOHB Protective Pathways in Aralar-KO Neurons and Brain: An Alternative to Ketogenic Diet</article-title>. <source>J Neurosci</source>
<volume>40</volume>: <fpage>9293</fpage>&#x02013;<lpage>9305</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">33087477</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Saito</surname><given-names>ER</given-names></name>, <name><surname>Warren</surname><given-names>CE</given-names></name>, <name><surname>Hanegan</surname><given-names>CM</given-names></name>, <name><surname>Larsen</surname><given-names>JG</given-names></name>, <name><surname>du Randt</surname><given-names>JD</given-names></name>, <name><surname>Cannon</surname><given-names>M</given-names></name>, <name><surname>Saito</surname><given-names>JY</given-names></name>, <name><surname>Campbell</surname><given-names>RJ</given-names></name>, <name><surname>Kemberling</surname><given-names>CM</given-names></name>, <name><surname>Miller</surname><given-names>GS</given-names></name>, <name><surname>Edwards</surname><given-names>JG</given-names></name>, and <name><surname>Bikman</surname><given-names>BT</given-names></name>. <article-title>A Novel Ketone-Supplemented Diet Improves Recognition Memory and Hippocampal Mitochondrial Efficiency in Healthy Adult Mice</article-title>. <source>Metabolites</source>
<volume>12</volume>: <year>2022</year>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Khalifa</surname><given-names>AR</given-names></name>, <name><surname>Abdel-Rahman</surname><given-names>EA</given-names></name>, <name><surname>Mahmoud</surname><given-names>AM</given-names></name>, <name><surname>Ali</surname><given-names>MH</given-names></name>, <name><surname>Noureldin</surname><given-names>M</given-names></name>, <name><surname>Saber</surname><given-names>SH</given-names></name>, <name><surname>Mohsen</surname><given-names>M</given-names></name>, and <name><surname>Ali</surname><given-names>SS</given-names></name>. <article-title>Sex-specific differences in mitochondria biogenesis, morphology, respiratory function, and ROS homeostasis in young mouse heart and brain</article-title>. <source>Physiol Rep</source>
<volume>5</volume>: <year>2017</year>.</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Petrick</surname><given-names>HL</given-names></name>, <name><surname>Brunetta</surname><given-names>HS</given-names></name>, <name><surname>Pignanelli</surname><given-names>C</given-names></name>, <name><surname>Nunes</surname><given-names>EA</given-names></name>, <name><surname>van Loon</surname><given-names>LJC</given-names></name>, <name><surname>Burr</surname><given-names>JF</given-names></name>, and <name><surname>Holloway</surname><given-names>GP</given-names></name>. <article-title>In vitro ketone-supported mitochondrial respiration is minimal when other substrates are readily available in cardiac and skeletal muscle</article-title>. <source>J Physiol</source>
<volume>598</volume>: <fpage>4869</fpage>&#x02013;<lpage>4885</lpage>, <year>2020</year>.<pub-id pub-id-type="pmid">32735362</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Cotter</surname><given-names>DG</given-names></name>, <name><surname>Schugar</surname><given-names>RC</given-names></name>, <name><surname>Wentz</surname><given-names>AE</given-names></name>, <name><surname>d&#x02019;Avignon</surname><given-names>DA</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation</article-title>. <source>Am J Physiol Endocrinol Metab</source>
<volume>304</volume>: <fpage>E363</fpage>&#x02013;<lpage>374</lpage>, <year>2013</year>.<pub-id pub-id-type="pmid">23233542</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Puchalska</surname><given-names>P</given-names></name>, <name><surname>Nelson</surname><given-names>AB</given-names></name>, <name><surname>Stagg</surname><given-names>DB</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Determination of ketone bodies in biological samples via rapid UPLC-MS/MS</article-title>. <source>Talanta</source>
<volume>225</volume>: <fpage>122048</fpage>, <year>2021</year>.<pub-id pub-id-type="pmid">33592770</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Dohm-Hansen</surname><given-names>S</given-names></name>, <name><surname>English</surname><given-names>JA</given-names></name>, <name><surname>Lavelle</surname><given-names>A</given-names></name>, <name><surname>Fitzsimons</surname><given-names>CP</given-names></name>, <name><surname>Lucassen</surname><given-names>PJ</given-names></name>, and <name><surname>Nolan</surname><given-names>YM</given-names></name>. <article-title>The &#x02018;middle-aging&#x02019; brain</article-title>. <source>Trends Neurosci</source>
<volume>47</volume>: <fpage>259</fpage>&#x02013;<lpage>272</lpage>, <year>2024</year>.<pub-id pub-id-type="pmid">38508906</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Stagg</surname><given-names>DB</given-names></name>, <name><surname>Gillingham</surname><given-names>JR</given-names></name>, <name><surname>Nelson</surname><given-names>AB</given-names></name>, <name><surname>Lengfeld</surname><given-names>JE</given-names></name>, <name><surname>d&#x02019;Avignon</surname><given-names>DA</given-names></name>, <name><surname>Puchalska</surname><given-names>P</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Diminished ketone interconversion, hepatic TCA cycle flux, and glucose production in D-beta-hydroxybutyrate dehydrogenase hepatocyte-deficient mice</article-title>. <source>Mol Metab</source>
<volume>53</volume>: <fpage>101269</fpage>, <year>2021</year>.<pub-id pub-id-type="pmid">34116232</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Atkinson</surname><given-names>DE</given-names></name>. <article-title>The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers</article-title>. <source>Biochemistry</source>
<volume>7</volume>: <fpage>4030</fpage>&#x02013;<lpage>4034</lpage>, <year>1968</year>.<pub-id pub-id-type="pmid">4972613</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>JC</given-names></name>, and <name><surname>Verdin</surname><given-names>E</given-names></name>. <article-title>Ketone bodies as signaling metabolites</article-title>. <source>Trends Endocrinol Metab</source>
<volume>25</volume>: <fpage>42</fpage>&#x02013;<lpage>52</lpage>, <year>2014</year>.<pub-id pub-id-type="pmid">24140022</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Brahma</surname><given-names>MK</given-names></name>, <name><surname>Wende</surname><given-names>AR</given-names></name>, and <name><surname>McCommis</surname><given-names>KS</given-names></name>. <article-title>CrossTalk opposing view: Ketone bodies are not an important metabolic fuel for the heart</article-title>. <source>J Physiol</source>
<volume>600</volume>: <fpage>1005</fpage>&#x02013;<lpage>1007</lpage>, <year>2022</year>.<pub-id pub-id-type="pmid">33644874</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Russell</surname><given-names>RR</given-names><suffix>3rd</suffix></name>, and <name><surname>Taegtmeyer</surname><given-names>H</given-names></name>. <article-title>Coenzyme A sequestration in rat hearts oxidizing ketone bodies</article-title>. <source>J Clin Invest</source>
<volume>89</volume>: <fpage>968</fpage>&#x02013;<lpage>973</lpage>, <year>1992</year>.<pub-id pub-id-type="pmid">1541685</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Pekala</surname><given-names>J</given-names></name>, <name><surname>Patkowska-Sokola</surname><given-names>B</given-names></name>, <name><surname>Bodkowski</surname><given-names>R</given-names></name>, <name><surname>Jamroz</surname><given-names>D</given-names></name>, <name><surname>Nowakowski</surname><given-names>P</given-names></name>, <name><surname>Lochynski</surname><given-names>S</given-names></name>, and <name><surname>Librowski</surname><given-names>T</given-names></name>. <article-title>L-carnitine--metabolic functions and meaning in humans life</article-title>. <source>Curr Drug Metab</source>
<volume>12</volume>: <fpage>667</fpage>&#x02013;<lpage>678</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21561431</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Burtscher</surname><given-names>J</given-names></name>, <name><surname>Di Pardo</surname><given-names>A</given-names></name>, <name><surname>Maglione</surname><given-names>V</given-names></name>, <name><surname>Schwarzer</surname><given-names>C</given-names></name>, and <name><surname>Squitieri</surname><given-names>F</given-names></name>. <article-title>Mitochondrial Respiration Changes in R6/2 Huntington&#x02019;s Disease Model Mice during Aging in a Brain Region Specific Manner</article-title>. <source>Int J Mol Sci</source>
<volume>21</volume>: <year>2020</year>.</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Veech</surname><given-names>RL</given-names></name>. <article-title>Ketone ester effects on metabolism and transcription</article-title>. <source>J Lipid Res</source>
<volume>55</volume>: <fpage>2004</fpage>&#x02013;<lpage>2006</lpage>, <year>2014</year>.<pub-id pub-id-type="pmid">24714648</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Vergara</surname><given-names>RC</given-names></name>, <name><surname>Jaramillo-Riveri</surname><given-names>S</given-names></name>, <name><surname>Luarte</surname><given-names>A</given-names></name>, <name><surname>Moenne-Loccoz</surname><given-names>C</given-names></name>, <name><surname>Fuentes</surname><given-names>R</given-names></name>, <name><surname>Couve</surname><given-names>A</given-names></name>, and <name><surname>Maldonado</surname><given-names>PE</given-names></name>. <article-title>The Energy Homeostasis Principle: Neuronal Energy Regulation Drives Local Network Dynamics Generating Behavior</article-title>. <source>Front Comput Neurosci</source>
<volume>13</volume>: <fpage>49</fpage>, <year>2019</year>.<pub-id pub-id-type="pmid">31396067</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Eloqayli</surname><given-names>H</given-names></name>, <name><surname>Melo</surname><given-names>TM</given-names></name>, <name><surname>Haukvik</surname><given-names>A</given-names></name>, and <name><surname>Sonnewald</surname><given-names>U</given-names></name>. <article-title>[2,4-(13)C]beta-hydroxybutyrate metabolism in astrocytes and C6 glioblastoma cells</article-title>. <source>Neurochem Res</source>
<volume>36</volume>: <fpage>1566</fpage>&#x02013;<lpage>1573</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21538079</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Escartin</surname><given-names>C</given-names></name>, <name><surname>Pierre</surname><given-names>K</given-names></name>, <name><surname>Colin</surname><given-names>A</given-names></name>, <name><surname>Brouillet</surname><given-names>E</given-names></name>, <name><surname>Delzescaux</surname><given-names>T</given-names></name>, <name><surname>Guillermier</surname><given-names>M</given-names></name>, <name><surname>Dhenain</surname><given-names>M</given-names></name>, <name><surname>Deglon</surname><given-names>N</given-names></name>, <name><surname>Hantraye</surname><given-names>P</given-names></name>, <name><surname>Pellerin</surname><given-names>L</given-names></name>, and <name><surname>Bonvento</surname><given-names>G</given-names></name>. <article-title>Activation of astrocytes by CNTF induces metabolic plasticity and increases resistance to metabolic insults</article-title>. <source>J Neurosci</source>
<volume>27</volume>: <fpage>7094</fpage>&#x02013;<lpage>7104</lpage>, <year>2007</year>.<pub-id pub-id-type="pmid">17611262</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Thevenet</surname><given-names>J</given-names></name>, <name><surname>De Marchi</surname><given-names>U</given-names></name>, <name><surname>Domingo</surname><given-names>JS</given-names></name>, <name><surname>Christinat</surname><given-names>N</given-names></name>, <name><surname>Bultot</surname><given-names>L</given-names></name>, <name><surname>Lefebvre</surname><given-names>G</given-names></name>, <name><surname>Sakamoto</surname><given-names>K</given-names></name>, <name><surname>Descombes</surname><given-names>P</given-names></name>, <name><surname>Masoodi</surname><given-names>M</given-names></name>, and <name><surname>Wiederkehr</surname><given-names>A</given-names></name>. <article-title>Medium-chain fatty acids inhibit mitochondrial metabolism in astrocytes promoting astrocyte-neuron lactate and ketone body shuttle systems</article-title>. <source>FASEB J</source>
<volume>30</volume>: <fpage>1913</fpage>&#x02013;<lpage>1926</lpage>, <year>2016</year>.<pub-id pub-id-type="pmid">26839375</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Jiang</surname><given-names>L</given-names></name>, <name><surname>Mason</surname><given-names>GF</given-names></name>, <name><surname>Rothman</surname><given-names>DL</given-names></name>, <name><surname>de Graaf</surname><given-names>RA</given-names></name>, and <name><surname>Behar</surname><given-names>KL</given-names></name>. <article-title>Cortical substrate oxidation during hyperketonemia in the fasted anesthetized rat in vivo</article-title>. <source>J Cereb Blood Flow Metab</source>
<volume>31</volume>: <fpage>2313</fpage>&#x02013;<lpage>2323</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21731032</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Puchalska</surname><given-names>P</given-names></name>, and <name><surname>Crawford</surname><given-names>PA</given-names></name>. <article-title>Metabolic and Signaling Roles of Ketone Bodies in Health and Disease</article-title>. <source>Annu Rev Nutr</source>
<volume>41</volume>: <fpage>49</fpage>&#x02013;<lpage>77</lpage>, <year>2021</year>.<pub-id pub-id-type="pmid">34633859</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Tieu</surname><given-names>K</given-names></name>, <name><surname>Perier</surname><given-names>C</given-names></name>, <name><surname>Caspersen</surname><given-names>C</given-names></name>, <name><surname>Teismann</surname><given-names>P</given-names></name>, <name><surname>Wu</surname><given-names>DC</given-names></name>, <name><surname>Yan</surname><given-names>SD</given-names></name>, <name><surname>Naini</surname><given-names>A</given-names></name>, <name><surname>Vila</surname><given-names>M</given-names></name>, <name><surname>Jackson-Lewis</surname><given-names>V</given-names></name>, <name><surname>Ramasamy</surname><given-names>R</given-names></name>, and <name><surname>Przedborski</surname><given-names>S</given-names></name>. <article-title>D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease</article-title>. <source>J Clin Invest</source>
<volume>112</volume>: <fpage>892</fpage>&#x02013;<lpage>901</lpage>, <year>2003</year>.<pub-id pub-id-type="pmid">12975474</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Johansson</surname><given-names>CJ</given-names></name>, and <name><surname>Pettersson</surname><given-names>G</given-names></name>. <article-title>Substrate-inhibiton by acetyl-CoA in the condensation reaction between oxaloacetate and acetyl-CoA catalyzed by citrate synthase from pig heart</article-title>. <source>Biochim Biophys Acta</source>
<volume>484</volume>: <fpage>208</fpage>&#x02013;<lpage>215</lpage>, <year>1977</year>.<pub-id pub-id-type="pmid">560867</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Taggart</surname><given-names>AK</given-names></name>, <name><surname>Kero</surname><given-names>J</given-names></name>, <name><surname>Gan</surname><given-names>X</given-names></name>, <name><surname>Cai</surname><given-names>TQ</given-names></name>, <name><surname>Cheng</surname><given-names>K</given-names></name>, <name><surname>Ippolito</surname><given-names>M</given-names></name>, <name><surname>Ren</surname><given-names>N</given-names></name>, <name><surname>Kaplan</surname><given-names>R</given-names></name>, <name><surname>Wu</surname><given-names>K</given-names></name>, <name><surname>Wu</surname><given-names>TJ</given-names></name>, <name><surname>Jin</surname><given-names>L</given-names></name>, <name><surname>Liaw</surname><given-names>C</given-names></name>, <name><surname>Chen</surname><given-names>R</given-names></name>, <name><surname>Richman</surname><given-names>J</given-names></name>, <name><surname>Connolly</surname><given-names>D</given-names></name>, <name><surname>Offermanns</surname><given-names>S</given-names></name>, <name><surname>Wright</surname><given-names>SD</given-names></name>, and <name><surname>Waters</surname><given-names>MG</given-names></name>. <article-title>(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G</article-title>. <source>J Biol Chem</source>
<volume>280</volume>: <fpage>26649</fpage>&#x02013;<lpage>26652</lpage>, <year>2005</year>.<pub-id pub-id-type="pmid">15929991</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Kimura</surname><given-names>I</given-names></name>, <name><surname>Inoue</surname><given-names>D</given-names></name>, <name><surname>Maeda</surname><given-names>T</given-names></name>, <name><surname>Hara</surname><given-names>T</given-names></name>, <name><surname>Ichimura</surname><given-names>A</given-names></name>, <name><surname>Miyauchi</surname><given-names>S</given-names></name>, <name><surname>Kobayashi</surname><given-names>M</given-names></name>, <name><surname>Hirasawa</surname><given-names>A</given-names></name>, and <name><surname>Tsujimoto</surname><given-names>G</given-names></name>. <article-title>Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>: <fpage>8030</fpage>&#x02013;<lpage>8035</lpage>, <year>2011</year>.<pub-id pub-id-type="pmid">21518883</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Suissa</surname><given-names>L</given-names></name>, <name><surname>Kotchetkov</surname><given-names>P</given-names></name>, <name><surname>Guigonis</surname><given-names>JM</given-names></name>, <name><surname>Doche</surname><given-names>E</given-names></name>, <name><surname>Osman</surname><given-names>O</given-names></name>, <name><surname>Pourcher</surname><given-names>T</given-names></name>, and <name><surname>Lindenthal</surname><given-names>S</given-names></name>. <article-title>Ingested Ketone Ester Leads to a Rapid Rise of Acetyl-CoA and Competes with Glucose Metabolism in the Brain of Non-Fasted Mice</article-title>. <source>Int J Mol Sci</source>
<volume>22</volume>: <year>2021</year>.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>De la Fuente</surname><given-names>IM</given-names></name>, <name><surname>Cortes</surname><given-names>JM</given-names></name>, <name><surname>Valero</surname><given-names>E</given-names></name>, <name><surname>Desroches</surname><given-names>M</given-names></name>, <name><surname>Rodrigues</surname><given-names>S</given-names></name>, <name><surname>Malaina</surname><given-names>I</given-names></name>, and <name><surname>Martinez</surname><given-names>L</given-names></name>. <article-title>On the dynamics of the adenylate energy system: homeorhesis vs homeostasis</article-title>. <source>PLoS One</source>
<volume>9</volume>: <fpage>e108676</fpage>, <year>2014</year>.<pub-id pub-id-type="pmid">25303477</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Hedskog</surname><given-names>L</given-names></name>, <name><surname>Pinho</surname><given-names>CM</given-names></name>, <name><surname>Filadi</surname><given-names>R</given-names></name>, <name><surname>Ronnback</surname><given-names>A</given-names></name>, <name><surname>Hertwig</surname><given-names>L</given-names></name>, <name><surname>Wiehager</surname><given-names>B</given-names></name>, <name><surname>Larssen</surname><given-names>P</given-names></name>, <name><surname>Gellhaar</surname><given-names>S</given-names></name>, <name><surname>Sandebring</surname><given-names>A</given-names></name>, <name><surname>Westerlund</surname><given-names>M</given-names></name>, <name><surname>Graff</surname><given-names>C</given-names></name>, <name><surname>Winblad</surname><given-names>B</given-names></name>, <name><surname>Galter</surname><given-names>D</given-names></name>, <name><surname>Behbahani</surname><given-names>H</given-names></name>, <name><surname>Pizzo</surname><given-names>P</given-names></name>, <name><surname>Glaser</surname><given-names>E</given-names></name>, and <name><surname>Ankarcrona</surname><given-names>M</given-names></name>. <article-title>Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer&#x02019;s disease and related models</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>110</volume>: <fpage>7916</fpage>&#x02013;<lpage>7921</lpage>, <year>2013</year>.<pub-id pub-id-type="pmid">23620518</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P33">KBs minimally drive respiration following Malate, ADP, CoA and Carnitine (A) Brain mitochondrial respiration protocol: Malate+ ADP+ AcAc (B) AcAc titrations were performed to determine maximal ketone-supported respiration (C) Respiration protocol: Malate +ADP + CoA + Carnitine + AcAc or D-&#x003b2;OHB (D) CoA and Carnitine were added to determine impact AcAc and BOHB supported respiration. (E) Succinyl-CoA maybe one key regulator in ketone supported respiration. All data are represented as &#x000b1; SEM and evaluated via one-way ANOVA, followed by a Fisher&#x02019;s LSD post hoc analysis. *P&#x0003c;0.05</p></caption><graphic xlink:href="nihms-2076859-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><p id="P34">Optimize aKG and AcAc concentration for AcAc supported respiration (A) Respiration protocol: Malate + ADP+ CoA + Carnitine + <bold>&#x003b1;</bold> ketoglutaric acid (<bold>&#x003b1;</bold>KG) + AcAc. (B) ADP-dependent (State III) respiration rate fueled by AcAc in isolated brain mitochondria in the presence of <bold>&#x003b1;</bold>KG. (C) Respiration protocol: Malate + ADP+ CoA + Carnitine + <bold>&#x003b1;</bold>KG + AcAc (D) AcAc titrations were performed to determine AcAc saturation in the presence of <bold>&#x003b1;</bold>kG.(E) Respiration protocol: Malate + ADP+ CoA + Carnitine + different concentration <bold>&#x003b1;</bold>KG +1 mM AcAc (F) Different concentration <bold>&#x003b1;</bold>kG were tried to maximize ketone respiration while minimizing <bold>&#x003b1;</bold>KG effects on brain mitochondria (G) Respiration protocol: Malate + ADP+ CoA + Carnitine + <bold>&#x003b1;</bold>KG + inhibitor (H) Respiration rate was measured in the absence of KBs and Malonic acid was added to measure complex II supported respiration fueled by <bold>&#x003b1;</bold>kG. n=3&#x02013;4 for all groups. All data are represented as &#x000b1; SEM and one-way ANOVA, followed by a Fisher&#x02019;s LSD post hoc analysis. *P&#x0003c;0.05; **P&#x0003c;0.01; ***P=0.0001; ****P&#x0003c;0.0001.</p></caption><graphic xlink:href="nihms-2076859-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><p id="P35">KBs supported respiration protocol (A) Respiration protocol: Malate + ADP+ CoA + Carnitine + <bold>&#x003b1;</bold>KG + AcAc or D-&#x003b2;OHB + Mna + Rot (B) ADP-dependent (state III) respiration rate supported by AcAc in isolated brain mitochondria were measured. (C) ADP-dependent (state III) respiration rate supported by D-&#x003b2;OHB in isolated brain mitochondria were measured. (D) AcAc or D-&#x003b2;OHB supported respiration calculated using Respiration (AcAc or D-&#x003b2;OHB)-Respiration(<bold>&#x003b1;</bold>KG); Complex I calculated using: Respiration (Mna)-Respiration (Rot); Complex II calculate using Respiration (AcAc or D-&#x003b2;OHB)-Respiration. N=5 for all groups. Data are represented as &#x000b1; SEM. Mna, Malonic acid, Rot, Rotenone. Fig. B and Fig. C are analyzed via one-way ANOVA, followed by a Fisher&#x02019;s LSD post hoc analysis. Fig. D is analyzed by by unpaired T test for each comparison between AcAc vs. D-&#x003b2;OHB. *P&#x0003c;0.05; ***P =0.0001; ****P&#x0003c;0.0001.</p></caption><graphic xlink:href="nihms-2076859-f0003" position="float"/></fig><fig position="float" id="F4"><label>Figure 4.</label><caption><p id="P36">Overview of experimental design: process for measuring respiration, metabolite level, and energy charge in isolated brain mitochondria.</p></caption><graphic xlink:href="nihms-2076859-f0004" position="float"/></fig><fig position="float" id="F5"><label>Figure 5.</label><caption><p id="P37">WT vs SCOT KO AcAc Supported Respiration. (A) Brain mitochondrial respiration protocol: Malate +ADP + CoA + Carnitine + AcAc (B). WT and KO show minimal AcAc supported respiration. (C). Brain mitochondrial respiration protocol: Malate +ADP + CoA + Carnitine + <bold><italic toggle="yes">&#x003b1;</italic></bold>KG+ AcAc +Mna or Rot. (D). ADP-dependent (state III) respiration rate supported by AcAc in isolated brain mitochondria were measured (E). AcAc supported respiration (Respiration<sub><bold><italic toggle="yes">&#x003b1;</italic></bold>KG+AcAc</sub> &#x02013;Respiration<sub><bold><italic toggle="yes">&#x003b1;</italic></bold>KG</sub>) in WT vs KO (F). Complex I (Respiration<sub><bold><italic toggle="yes">&#x003b1;</italic></bold>KG+AcAc</sub> &#x02013;Respiration <sub>Rot</sub>) and Complex II (Respiration<sub><bold><italic toggle="yes">&#x003b1;</italic></bold>KG+AcAc</sub> &#x02013; Respiration <sub>Mna</sub>) supported respiration in WT vs KO. N=8 for all groups. Data are represented as &#x000b1; SEM. Mna, Malonic acid, Rot, Rotenone. For Fig. B, Fig. D, and Fig. F, data are analyzed by two-way ANOVA analysis, followed by a Fisher&#x02019;s LSD post hoc test. For Fig. E, data is analyzed via unpaired T test. *<italic toggle="yes">P&#x0003c;0.05;</italic> ***<italic toggle="yes">P=0.0001;</italic> ****<italic toggle="yes">P&#x0003c;0.0001.</italic></p></caption><graphic xlink:href="nihms-2076859-f0005" position="float"/></fig><fig position="float" id="F6"><label>Figure 6.</label><caption><p id="P38">No significant genotype difference in <bold><italic toggle="yes">&#x003b1;</italic></bold>KG Supported Respiration and metabolite profile. (A). Brain mitochondrial respiration protocol: Malate +ADP + CoA + Carnitine + <bold><italic toggle="yes">&#x003b1;</italic></bold>KG vs <bold><italic toggle="yes">&#x003b1;</italic></bold>KG +Mna vs <bold><italic toggle="yes">&#x003b1;</italic></bold>KG + Rot (B). Final respiration status prior to metabolite analysis (C). Acetyl-CoA level for all three conditions (D). Energy charge for all three conditions calculated using AMP, ADP, and ATP. N=8 for all groups. All data are represented as &#x000b1; SEM. Mna, Malonic acid, Rot, Rotenone. All data are analyzed via unpaired T test to compare the control and SCOT KO in each condition.</p></caption><graphic xlink:href="nihms-2076859-f0006" position="float"/></fig><fig position="float" id="F7"><label>Figure 7.</label><caption><p id="P39">SCOT KO has a lower acetyl-CoA level using <bold><italic toggle="yes">&#x003b1;</italic></bold>KG +AcAc as the fuel source. (A) Brain mitochondrial respiration protocol: Malate +ADP + CoA + Carnitine vs AcAc vs <bold><italic toggle="yes">&#x003b1;</italic></bold>KG +AcAc vs <bold><italic toggle="yes">&#x003b1;</italic></bold>KG +AcAc +Mna vs <bold><italic toggle="yes">&#x003b1;</italic></bold>KG + AcAc+ Rot (B) Final respiration status prior to metabolite analysis (C). Acetyl-CoA level for all five conditions (D). Energy charge for all five conditions calculated using AMP, ADP, and ATP. N=8 for all groups. Data are represented as &#x000b1; SEM. Mna, Malonic acid, Rot, Rotenone. All data are analyzed via unpaired T test to compare the control and SCOT KO in each condition. *<italic toggle="yes">P&#x0003c;0.05</italic>.</p></caption><graphic xlink:href="nihms-2076859-f0007" position="float"/></fig></floats-group></article>